 Loughborough, England, March 25, 2021 GLOBE NEWSWIRE -- Nemaura Medical, Inc. NASDAQ: NMRD Nemaura or the Company, a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces that it has retained Paul Kennedy who will be advising the Company on its commercial growth initiatives. 